Jonathan Goldman, Abzena CEO
April 12, 2022 01:22 PM EDTUpdated 02:22 PM
Pharma
Manufacturing

Abzena com­mits chunk of new $65M in­vest­ment to build out in hot North Car­oli­na scene

Josh Sullivan

A San Diego CD­MO has land­ed a $65 mil­lion in­vest­ment to ex­pand its drug sub­stance and fill-fin­ish man­u­fac­tur­ing ca­pac­i­ty, and it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

GSK makes an­oth­er ADC deal, this time with BioN­Tech's part­ner Du­al­i­ty­Bio

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

A service from the Financial Times